CVR number 34200904
Industry 75.0000 Veterinary activities

LVK DYRLÆGERNE A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.6% 1.9% 2.3% 1.9% 3.9%  
Credit score (0-100)  61 69 64 69 51  
Credit rating  BBB A BBB A BBB  
Credit limit (kDKK)  0.0 5.4 0.3 4.4 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  39,406 39,306 37,926 38,659 38,700  
EBITDA  1,238 2,518 2,101 912 452  
EBIT  236 1,775 1,201 302 -36.4  
Pre-tax profit (PTP)  305.0 1,842.0 1,265.0 404.0 62.3  
Net earnings  231.0 1,460.0 993.0 312.0 56.9  
Pre-tax profit without non-rec. items  305 1,842 1,265 404 62.3  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  1,441 1,499 925 828 916  
Shareholders equity total  6,161 7,621 6,615 6,927 5,984  
Interest-bearing liabilities  86.0 193 301 1,485 117  
Balance sheet total (assets)  14,285 15,812 13,478 16,860 12,394  
Net Debt  -913 -1,076 -84.0 -1,842 -239  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  39,406 39,306 37,926 38,659 38,700  
Gross profit growth  3.9% -0.3% -3.5% 1.9% 0.1%  
Employees  45 42 42 42 41  
Employee growth %  0.0% -6.7% 0.0% 0.0% -2.4%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  14,285 15,812 13,478 16,860 12,394  
Balance sheet change%  5.2% 10.7% -14.8% 25.1% -26.5%  
Added value  1,238.0 2,518.0 2,101.0 1,202.0 452.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -1,158 -262 -1,601 -824 -518  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 -1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.6% 4.5% 3.2% 0.8% -0.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.2% 12.3% 8.7% 2.7% 0.4%  
ROI %  4.9% 26.2% 17.2% 5.3% 0.9%  
ROE %  3.8% 21.2% 14.0% 4.6% 0.9%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  43.1% 48.2% 49.1% 41.1% 48.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -73.7% -42.7% -4.0% -202.0% -52.8%  
Gearing %  1.4% 2.5% 4.6% 21.4% 2.0%  
Net interest  0 0 0 0 0  
Financing costs %  1.5% 2.9% 1.2% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.4 1.5 1.6 1.5 1.5  
Current Ratio  1.6 1.7 1.8 1.6 1.8  
Cash and cash equivalent  999.0 1,269.0 385.0 3,327.0 355.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  4,672.0 5,623.0 5,318.0 5,844.0 4,929.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  28 60 50 29 11  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  28 60 50 22 11  
EBIT / employee  5 42 29 7 -1  
Net earnings / employee  5 35 24 7 1